100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
10417-63-716α-Methyl Prednisolone
● Auf Lager
| Katalog-Nr.:: | VE009512 |
|---|---|
| CAS-Nr.:: | 10417-63-7 |
| Summenformel:: | C22H30O5 |
| Molare Masse:: | 374.47 g/mol |
Zusätzliche Informationen zu CAS 10417-63-7
Parent drug
PrednisoloneIUPAC-Name
(8S, 9S, 10R, 11S, 13S, 14S, 16R, 17R)-11, 17-dihydroxy-17-(2-hydroxyacetyl)-10, 13, 16-trimethyl-6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-dodecahydro-3H-cyclopenta[a]phenanthren-3-oneSynonyme
N/ABeschreibung
16α-Methyl Prednisolone (CAS No: 10417-63-7) Or (8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-17-(2-hydroxyethyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one, 16α-Methyl Prednisolone is an impurity present in Prednisolone,Prednisone is a synthetic, anti-inflammatory glucocorticoid that derives from cortisone. delayed-release corticosteroid is indicated as an anti-inflammatory or immunosuppressive agent to treat a broad range of diseases, including immunosuppressive neoplastic, edematous, gastrointestinal, and acute exacerbations of multiple sclerosis, and as an anti-inflammatory and antineoplastic agent.References
Puckett, Y., Aishah Gabbar, & Bokhari, A. A. (2022, May 8). Prednisone. Retrieved June 16, 2022, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK534809/Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Prednisolone impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
